|
Vicki L. Goodman
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 2.08 per share. |
10 Nov 2025 |
5,036 |
84,727
|
-
|
2.1 |
10,475
|
Ordinary Shares |
|
Adam D. Cutler
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 2.09 per share. |
03 Nov 2025 |
7,148 |
99,290
|
-
|
2.1 |
14,939
|
Ordinary Shares |
|
Maiken Keson-Brookes
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.48 per share. |
22 Jul 2025 |
2,572 |
68,834
|
-
|
2.5 |
6,379
|
Ordinary Shares |
|
Maiken Keson-Brookes
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 2.48 per share. |
18 Jul 2025 |
2,158 |
71,406
|
-
|
2.5 |
5,352
|
Ordinary Shares |
|
Caroline Loew
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 2.43 per share. |
07 Jul 2025 |
12,531 |
293,059
|
-
|
2.4 |
30,475
|
Ordinary Shares |
|
Sachiyo Minegishi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
8,637 |
8,637
|
-
|
|
-
|
Stock Option (right to buy) |
|
Benjamin J. Hickey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
8,637 |
8,637
|
-
|
|
-
|
Stock Option (right to buy) |
|
George S. Golumbeski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
8,637 |
8,637
|
-
|
|
-
|
Stock Option (right to buy) |
|
Francis M. Cuss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
8,637 |
8,637
|
-
|
|
-
|
Stock Option (right to buy) |
|
Scott T. Jackson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2025 |
8,637 |
8,637
|
-
|
|
-
|
Stock Option (right to buy) |
|
Caroline Loew
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 3.36 per share. |
03 Mar 2025 |
4,313 |
305,590
|
-
|
3.4 |
14,492
|
Ordinary Shares |
|
Maiken Keson-Brookes
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
35,000 |
76,295
|
-
|
|
0
|
Ordinary Shares |
|
Maiken Keson-Brookes
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Maiken Keson-Brookes
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.45 per share. |
03 Mar 2025 |
1,469 |
73,564
|
-
|
3.4 |
5,068
|
Ordinary Shares |
|
Maiken Keson-Brookes
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.36 per share. |
03 Mar 2025 |
1,262 |
75,033
|
-
|
3.4 |
4,240
|
Ordinary Shares |
|
Adam D. Cutler
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
35,000 |
106,438
|
-
|
|
0
|
Ordinary Shares |
|
Adam D. Cutler
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Vicki L. Goodman
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Vicki L. Goodman
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
35,000 |
89,763
|
-
|
|
0
|
Ordinary Shares |
|
Caroline Loew
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
72,275 |
309,903
|
-
|
|
0
|
Ordinary Shares |
|
Caroline Loew
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
134,225 |
134,225
|
-
|
|
-
|
Stock Option (right to buy) |
|
Vicki L. Goodman
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 3.89 per share. |
24 Feb 2025 |
13,186 |
54,763
|
-
|
3.9 |
51,294
|
Ordinary Shares |
|
Keson-Brookes Maiken
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.27 per share. |
23 Dec 2024 |
2,555 |
41,295
|
-
|
3.3 |
8,355
|
Ordinary Shares |
|
Loew Caroline
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 3.40 per share. |
17 Dec 2024 |
2,763 |
237,628
|
-
|
3.4 |
9,394
|
Ordinary Shares |
|
Vicki L. Goodman
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 3.33 per share. |
07 Nov 2024 |
5,069 |
67,949
|
-
|
3.3 |
16,880
|
Ordinary Shares |
|
Adam D. Cutler
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 3.41 per share. |
31 Oct 2024 |
7,421 |
71,438
|
-
|
3.4 |
25,306
|
Ordinary Shares |
|
Sachiyo Minegishi
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Sep 2024 |
15,335 |
15,335
|
-
|
|
-
|
Stock Option (right to buy) |
|
Susan Altschuller
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.21 per share. |
14 Aug 2024 |
10,000 |
10,000
|
-
|
3.2 |
32,071
|
Ordinary Shares |
|
George S. Golumbeski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jul 2024 |
15,334 |
15,334
|
-
|
|
-
|
Stock Option (right to buy) |
|
Maiken Keson-Brookes
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 3.41 per share. |
18 Jul 2024 |
2,157 |
43,850
|
-
|
3.4 |
7,355
|
Ordinary Shares |
|
Caroline Loew
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 2.91 per share. |
08 Jul 2024 |
12,531 |
240,391
|
-
|
2.9 |
36,465
|
Ordinary Shares |
|
Susan Altschuller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Benjamin J. Hickey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Francis M. Cuss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Scott T. Jackson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Susan Altschuller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Benjamin J. Hickey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Francis M. Cuss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Scott T. Jackson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 May 2024 |
8,462 |
8,462
|
-
|
|
-
|
Stock Option (right to buy) |
|
Maiken Keson-Brookes
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
31,200 |
31,200
|
-
|
|
-
|
Stock Option (right to buy) |
|
Maiken Keson-Brookes
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
16,800 |
46,007
|
-
|
|
0
|
Ordinary Shares |
|
Caroline Loew
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
48,475 |
252,922
|
-
|
|
0
|
Ordinary Shares |
|
Caroline Loew
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
90,025 |
90,025
|
-
|
|
-
|
Stock Option (right to buy) |
|
Susan Altschuller
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
15,021 |
15,021
|
-
|
|
-
|
Stock Option (right to buy) |
|
Benjamin J. Hickey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
15,021 |
15,021
|
-
|
|
-
|
Stock Option (right to buy) |
|
Adam D. Cutler
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
78,859 |
78,859
|
-
|
|
0
|
Ordinary Shares |
|
Adam D. Cutler
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
146,452 |
146,452
|
-
|
|
-
|
Stock Option (right to buy) |
|
Maiken Keson-Brookes
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
29,207 |
29,207
|
-
|
|
0
|
Ordinary Shares |
|
Maiken Keson-Brookes
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
54,242 |
54,242
|
-
|
|
-
|
Stock Option (right to buy) |
|
Francis M. Cuss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
15,021 |
15,021
|
-
|
|
-
|
Stock Option (right to buy) |
|
Scott T. Jackson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
15,021 |
15,021
|
-
|
|
-
|
Stock Option (right to buy) |
|
Vicki L. Goodman
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
73,018 |
73,018
|
-
|
|
0
|
Ordinary Shares |
|
Vicki L. Goodman
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
135,604 |
135,604
|
-
|
|
-
|
Stock Option (right to buy) |
|
Caroline Loew
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2023 |
379,690 |
379,690
|
-
|
|
-
|
Stock Option (right to buy) |